US IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%;...read more
Liquid Holdings Group, which provides an integrated, on-demand software platform for small hedge funds, raised $29 million by offering 3.2 million shares (all primary) at $9, the low end of the range of $9 to $11. Liquid Holdings Group plans to list on the...read more
Liquid Holdings Group, which provides an integrated, on-demand software platform for small hedge funds, lowered the proposed deal size for its upcoming IPO on Wednesday. The New York, NY-based company now plans to raise $42 million by offering 4.2 million shares...read more
US IPO Recap: 11 deals price in busiest week since November 2007, eight companies set terms
US IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%;...read more
Liquid Holdings Group prices downsized IPO at $9, low end of the range
Liquid Holdings Group, which provides an integrated, on-demand software platform for small hedge funds, raised $29 million by offering 3.2 million shares (all primary) at $9, the low end of the range of $9 to $11. Liquid Holdings Group plans to list on the...read more
Liquid Holdings Group removes insider selling, decreasing proposed IPO deal size
Liquid Holdings Group, which provides an integrated, on-demand software platform for small hedge funds, lowered the proposed deal size for its upcoming IPO on Wednesday. The New York, NY-based company now plans to raise $42 million by offering 4.2 million shares...read more
12 US IPOs planned for the week of Jul 22
The following IPOs are expected to price this week: Agios Pharmaceuticals (AGIO), a biotech developing metabolic treatments for cancer and rare genetic diseases, plans...read more